FIGURE 1.
Patient flow diagram. Flow diagram of patients with newly diagnosed classic Hodgkin lymphoma enrolled in the JCOG1305 study using interim PET‐guided ABVD or ABVD/escalated BEACOPP therapy. ABVD, doxorubicin, bleomycin, vinblastine, and dacarbazine; eBEACOPP, escalated bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone; ISRT, involved site radiation therapy; PET, positron emission tomography.